Simultaneously, enhance brain ischemia/subarachnoid hemorrhage injury, decrease neuroinflammation, limit astrocyte and microglia activation, and lower IL-1β levels (Ren et al., 2023; Wang et al., 2017; Chen et al., 2013). This evidence concerns the gene IL1B and subarachnoid hemorrhage.